Duexis FDA Approval History
FDA Approved: Yes (First approved April 23, 2011)
Brand name: Duexis
Generic name: famotidine and ibuprofen
Dosage form: Tablets
Company: Horizon Pharma, Inc.
Treatment for: Osteoarthritis, Rheumatoid Arthritis, NSAID-Induced Ulcer Prophylaxis
Duexis (ibuprofen and famotidine) is an NSAID and histamine H2-receptor antagonist combination indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper GI ulcers.
Development Timeline for Duexis
|Apr 25, 2011||Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)|
|May 26, 2010||Horizon Pharma, Inc. Announces FDA Acceptance of Duexa New Drug Application for Filing|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.